Vizsgálati helyszín
Heiwadai Hospital_Internal Medicine
Miyazaki, Miyazaki 880-0034, JapánMég nincs intézményhez kötve
Az itteni vizsgálatok
Miről szól a helyszín 10 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 3. fázis8 vizsgálat
- 2. fázis1 vizsgálat
- Fő szponzor
- Novo Nordisk A/S10 vizsgálat
Lezárt vizsgálatok
Lezárult
A Research Study to See if Two Different Formulations of Oral Semaglutide Are Equally Safe and Effective in Reducing the Blood Sugar Level in Japanese People With Type 2 Diabetes
NCT07271251· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes
NCT06542874· 2. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 Diabetes
NCT06340854· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4)
NCT06269107· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose Weight
NCT05813925· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec
NCT05352815· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)
NCT05259033· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)
NCT05013229· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
Post-Marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ozempic®
NCT04469855· Novo Nordisk A/S· Forrás
Lezárult
A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes
NCT03914326· 3. fázis· Novo Nordisk A/S· Forrás
Hibát jelzek